SEC Form 4 · accession 0001209191-16-113173
HTG MOLECULAR DIAGNOSTICS, INC · HTGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shaun D McMeans
Officer — VP, Finance & Admin. & CFO
Period of report
Apr 1, 2016
Accepted (ET)
Apr 5, 2016 · 5:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001169987
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Apr 1, 2016 | S | 1,426 | $2.8888 | D | 20,151 | D | |
| Common StockF3 | Apr 4, 2016 | S | 175 | $2.9236 | D | 19,976 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Sale of shares of common stock under an existing Rule 10b5-1 Plan to cover tax withholding obligations incurred in connection with the vesting of the restricted stock units acquired by the Reporting Person on August 27, 2015.
- F2The weighted average sale price for the transaction reported was $2.8887675, and the range of prices were between $2.80 and $2.97. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- F3The weighted average sale price for the transaction reported was $2.9236, and the range of prices were between $2.86 and $3.03. Upon request by the SEC staff, the Issuer, or any securityholder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.